Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[QT syndrome: new diagnostic possibilities]

T Lewalter1, S Englisch, S Jahr

  • 1Medizinische Universitätsklinik und Poliklinik Bonn.

Zeitschrift Fur Kardiologie
|September 23, 1998
PubMed
Summary

Genetic testing aids in diagnosing long QT syndrome (LQTS), especially in borderline cases. It also improves risk assessment and guides personalized treatment for LQTS patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of obstructive sleep apnea on heart rate turbulence.

Basic research in cardiology·2005
Same author

[Postoperative arrhythmias].

Deutsche medizinische Wochenschrift (1946)·2005
Same author

[Atrial fibrillation -- interventional therapy with respect to age].

Deutsche medizinische Wochenschrift (1946)·2005
Same author

Progression of native coronary plaques and in-stent restenosis are associated and predicted by increased pre-procedural C reactive protein.

Heart (British Cardiac Society)·2005
Same author

Atrial fibrillation: profit from cardiac pacing?

Zeitschrift fur Kardiologie·2005
Same author

[Progressive upper lobe consolidation in a 73-year old healthy woman].

Der Internist·2005

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Context:

  • Long QT syndrome (LQTS) diagnosis relies on electrocardiographic and clinical criteria.
  • Borderline findings in LQTS present diagnostic challenges, impacting clinical decision-making.
  • Schwartz's point system is a traditional tool for LQTS assessment.

Purpose:

  • To explore the role of genetic diagnostics in evaluating long QT syndrome.
  • To investigate genetic heterogeneity and its impact on LQTS diagnosis and risk stratification.
  • To assess the potential of molecular genetics in guiding pharmacological therapy for LQTS.

Summary:

  • Genetic diagnostics offer significant advancements for LQTS assessment, particularly in patients with borderline electrocardiographic and clinical findings.
  • Linkage analysis has identified LQTS loci on chromosomes 11, 3, 7, and 4, with genes for LQT1, LQT2, and LQT3 now identified.
  • Molecular genetic analysis reveals diverse mutations, highlighting genetic heterogeneity and aiding in risk stratification and targeted therapy.

Impact:

  • Genetic testing enhances diagnostic accuracy for long QT syndrome.
  • Molecular insights facilitate improved risk stratification for LQTS family members.
  • Identifying specific ion-channel defects guides personalized pharmacological treatment strategies for LQTS, potentially preventing sudden death.

Related Experiment Videos